CTIS2023-506395-27-00招募中1 期
DETOUR; Determining the safety and feasibility of optical coherencetomography and near infrared fluorescence: a prospective pilotintervention study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- •Indication for a therapeutic endoscopy procedure (EMR or ESD), Age = 18, Written informed consent
排除标准
- •Submucosal and invasive EAC or CRC, Radiation therapy for esophageal or colorectal cancer, History of infusion reactions to Bevacizumab or other monoclonal antibodies, Chemotherapy, immunotherapy or surgery 28 days before administration of the tracer, Non-adjustable hypertension, Medical or psychiatric conditions that compromise the patient’s ability to give informed consent, Pregnancy or breast feeding; a negative pregnancy test must be available for women of childbearing potential
研究者
相似试验
招募中
1 期
The Safety and feasibility of Intra-Arterial Stem Cell Therapy In Patients with Sub-Acute StrokeIschemic stroke.Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesIRCT2016051327865N1Vice Chancellor for Research and Technology, Iran University of Medical Sciences4
已完成
1 期
Evaluation of the safety and feasibility of intra ovarian injection of menstrual blood derived stem cells (MenSCs) in women with poor ovarian response.IRCT20180619040147N2Iranian Academic Center for Education Culture and Research36
进行中(未招募)
1 期
Investigating the safety, feasibility, and optimal dose of Adalimumab-680LT in IBD – GUIDE studyCTIS2023-508391-11-00niversitair Medisch Centrum Groningen18
已完成
不适用
Exercise training in patients awaiting a liver transplantation: a randomised control trialiver TransplantExercise TrainingLiver TransplantPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationACTRN12614000791639Mr Matthew Wallen21
已完成
不适用
STUDY TO EVALUATE THE SAFETY AND VIABILITY OF THE IMPLEMENTATION OF NT-503 IN THE VITTURAL CAVITY FOR THE TREATMENT OF SUBFOVEAL COROID NEOVASCULARIZATION (NVC) SECONDARY TO AGE-ASSOCIATED MACULAR DEGENERATION (DMAE)PER-163-08EUROTECH,
